FDA Brief

Warning letters Drugs

FDA warning letter to

CalmCo LLC previously named Ketomi LLC

High riskIssued Aug 9, 2023Posted Aug 15, 2023Center for Drug Evaluation and Research | CDER

FDA warns CalmCo that Colic Calm and Colic Calm + are unapproved new drugs for infants.

What happened

FDA reviewed www.coliccalm.com in May 2023 and the product labels. FDA found that CalmCo offers Colic Calm and Colic Calm + for sale with claims to relieve infant colic, gas, reflux, upset stomach, bloating, and hiccups. FDA determined the products are unapproved new drugs because no approved application is in effect and they are not generally recognized as safe and effective for those uses; the letter also cites a related CGMP (current good manufacturing practice) warning letter to Denison Pharmaceuticals.

What FDA found

  1. FDA says Colic Calm and Colic Calm + are unapproved new drugs because they are intended to treat infant colic, gas, reflux, and related symptoms and no FDA-approved application is in effect.

    FD&C Act §§ 505(a), 301(d), 201(p); 21 U.S.C. 355(a), 331(d), 321(p)
  2. The product labels and website claims show the products are intended to cure, mitigate, treat, or prevent disease or affect body function, making them drugs.

    FD&C Act § 201(g)(1), 21 U.S.C. 321(g)(1)
  3. Labeling the products as homeopathic does not exempt them from the same drug approval, adulteration, and misbranding requirements.

    FD&C Act § 201(g)(1), 21 U.S.C. 321(g)(1)

What FDA wants

FDA asks CalmCo to notify it in writing within 15 working days of the steps taken to correct the violations and prevent recurrence, with supporting documentation. If CalmCo believes the products are not in violation, it must include its reasoning and supporting information.

Who should pay attention

  • parents and caregivers of infants
  • retailers and online sellers of infant gripe water
  • contract manufacturers and brands of homeopathic infant drugs

This is a summary. Read the original letter on fda.gov.

Similar letters to other companies

  1. New Green Nutrition Inc.

    FDA says New Green Nutrition sold unapproved drugs online, and its Qu Feng Huo Luo Dan contained hidden dexamethasone.

    High risk
  2. Ong Tien USA LLC

    FDA warned Ong Tien USA LLC that its herbal joint products are unapproved drugs and one contained hidden piroxicam and dexamethasone.

    High risk
  3. Jing Cheong Asia Inc. dba New York Tong Ren Tang

    New York Tong Ren Tang marketed unapproved new drugs, including eye drops, on its website.

    High risk
  4. Phuoc Loc Tho Herbals, Inc.

    FDA warned Phuoc Loc Tho Herbals that its herbal products are unapproved new drugs marketed with disease claims.

    High risk